Indication

Bacterial blepharitis

Bacterial blepharitis is an acute or chronic inflammatory disease of the ocular system, primarily involving the margins of the eyelids and eyelash follicles due to bacterial colonization or infection, most frequently by *Staphylococcus aureus* or coagulase-negative staphylococci. Read more about Bacterial blepharitis

89 drugs 35 manufacturers

Advertisement

Drugs that treat it

Common Bacterial blepharitis therapies.

Showing 73–81 of 89 drugs

TOBRAMYCIN

OPHTHALMIC ANTIBACTERIALS·KERATOCONJUNCTIVITIS·+5
A-S MEDICATION

TOBRAMYCIN

OPHTHALMIC ANTIBACTERIALS·KERATOCONJUNCTIVITIS·+5
DIRECT RX

TOBRAMYCIN

OPHTHALMIC ANTIBACTERIALS·KERATOCONJUNCTIVITIS·+5
PROFICIENT RX L
Filter & compare in the drug finder →Opens the drug finder with Bacterial blepharitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Bacterial blepharitis.

Bacterial blepharitis is an acute or chronic inflammatory disease of the ocular system, primarily involving the margins of the eyelids and eyelash follicles due to bacterial colonization or infection, most frequently by *Staphylococcus aureus* or coagulase-negative staphylococci.

Pathophysiologically, the condition results from a combination of direct bacterial invasion, production of bacterial exotoxins, and localized host immune hypersensitivity responses.

Clinically, it presents with bilateral lid margin erythema, edema, itching, burning, and characteristic hard crusting or collarettes surrounding the bases of the eyelashes, which may lead to lash matting upon waking, madarosis, or secondary conjunctival irritation.

Personalize your experience

Follow Bacterial blepharitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it